UK markets close in 4 hours 15 minutes

Immix Biopharma, Inc. (IMMX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.3100+0.1400 (+6.45%)
At close: 04:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
17,510
13,437
17,644
391.086
Total cash
17,510
13,437
17,644
391.086
Other current assets
44.582
78.067
516.193
13.714
Total current assets
19,788
14,898
18,186
532.236
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
50.181
3.56
5.695
7.361
Net property, plant and equipment
50.181
3.56
5.695
7.361
Other long-term assets
-
6.724
-
-
Total non-current assets
137.41
10.284
5.695
7.361
Total assets
19,925
14,908
18,192
539.597
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
50
4,100
Accounts payable
1,433
143.074
142.94
252.344
Accrued liabilities
2,289
1,130
9.099
342.837
Other current liabilities
-
-
-
575
Total current liabilities
3,722
1,273
202.039
5,270
Non-current liabilities
Total non-current liabilities
0
475
0
0
Total liabilities
3,722
1,748
202.039
5,270
Stockholders' equity
Common stock
2
1.397
1.323
0.338
Retained earnings
-53,411
-37,985
-29,756
-5,372
Accumulated other comprehensive income
134.666
87.021
125.408
131.861
Total stockholders' equity
16,405
13,160
17,990
-4,731
Total liabilities and stockholders' equity
19,925
14,908
18,192
539.597